Combination of stromal-derived factor-1α and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization

被引:104
作者
Yu, Jian-Xing [1 ]
Huang, Xue-Fei [3 ]
Lv, Wei-Ming [1 ]
Ye, Cai-Sheng [1 ]
Peng, Xin-Zhi [1 ]
Zhang, Hui [2 ]
Xiao, Long-Bin [4 ]
Wang, Shen-Ming [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510080, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510080, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510080, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Huangpu Div Hosp, Dept Gastrointestinal Pancreat Surg, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
DOUBLE-BLIND; FACTOR-I; RECRUITMENT; ANGIOGENESIS; CXCR4; INVOLVEMENT; EXPRESSION;
D O I
10.1016/j.jvs.2009.05.049
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Recruitment and entrapment of bone marrow-derived endothelial progenitor cells (EPCs) is important in vascular endothelial growth factor (V-EGF)-induced angiogenesis. EPC mobilization and differentiation are modulated by stromal-derived factor-1 alpha (SDF-1 alpha/CXCL12), another important chemokine. In this study, we investigated the hypothesis that SDF-1 alpha and VEGF might act synergistically on EPC-mediated vasculogenesis. Methods: EPCs were isolated and cultured from human peripheral blood, then transduced with retroviral vectors pBabe containing human VEGF(165) complimentary DNA (Td/V-EPCs) and pBabe wild-type (Td/p-EPCs). EPC migration activity was investigated with a modified Boyden chamber assay. EPC apoptosis induced by serum starvation was studied by annexin V assays. The combined effect of local administration of SDF-1 alpha and Td/V-EPC transplantation on neovascularization was investigated in a murine model of hind limb ischemia. Results. Over-expression of hV-EGF(165) increased SDF-1 alpha-mediated EPC migration. SDF-1 alpha-mediated migration was significantly increased when EPCs were modified with VEGF (Td/V-EPCs) vs when VEGF was not present (Td/p-EPCs) or when VEGF alone was present (Td/V-EPCs; 196.8 +/- 15.2, 81.2 +/- 9.8, and 67.4 +/- 7.4/mm(2), respectively P < .001). SDF-1 alpha combined with VEGF reduced serum starvation-induced apoptosis of EPCs more than SDF-1 alpha or VEGF alone (P < .001). To determine the effect of this combination in vivo, SDF-1 alpha was locally injected alone into the ischemic hind limb muscle of nude mice or combined with systemically injected Td/V-EPCs. The SDF-1 alpha plus VEGF group showed significantly increased local accumulation of EPCs, blood-flow recovery, and capillary density compared with the other groups. The ratio of ischemic/normal blood flow in Td/V-EPCs plus SDF-1 alpha group was significantly higher (P < .01), as was capillary density (capillaries/mm(2)), an index of neovascularization (Td/V-EPCs plus SDF-1 alpha group, 863 31; no treatment, 395 +/- 13; SDF-1 alpha, 520 +/- 29; Td/p-EPCs, 448 +/- 28; Td/p-EPCs plus SDF-1 alpha., 620 +/- 29; Td/V-EPCs, 570 +/- 30; P < .01). To investigate a possible mechanistic basis, we showed that VEGF up-regulated the receptor for SDF-1 alpha, CXCR4, on EM in Nitro. Conclusion: The combination of SDF-1 alpha and VEGF greatly increases EPC-mediated angiogenesis. The use VEGF and SDF-1 alpha together, rather than alone, will be a novel and efficient angiogenesis strategy to provide therapeutic neovascularization. (J Vase Surg 2009;50:608-16.)
引用
收藏
页码:608 / 616
页数:9
相关论文
共 18 条
  • [1] Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and Gai proteins and enhances engraftment of competitive, repopulating stem cells
    Broxmeyer, HE
    Kohli, L
    Kim, CH
    Lee, YH
    Mantel, C
    Cooper, S
    Hangoc, G
    Shaheen, M
    Li, XX
    Clapp, DW
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (05) : 630 - 638
  • [2] SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells
    De Falco, E
    Porcelli, D
    Torella, AR
    Straino, S
    Iachininoto, MG
    Orlandi, A
    Truffa, S
    Biglioli, P
    Napolitano, M
    Capogrossi, MC
    Pesce, M
    [J]. BLOOD, 2004, 104 (12) : 3472 - 3482
  • [3] Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease
    Heeschen, C
    Lehmann, R
    Honold, J
    Assmus, B
    Aicher, A
    Walter, DH
    Martin, H
    Zeiher, AM
    Dimmeler, S
    [J]. CIRCULATION, 2004, 109 (13) : 1615 - 1622
  • [4] Gene transfer of stromal cell-derived factor-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway -: Next-generation chemokine therapy for therapeutic neovascularization
    Hiasa, K
    Ishibashi, M
    Ohtani, K
    Inoue, S
    Zhao, QW
    Kitamoto, S
    Sata, M
    Ichiki, T
    Takeshita, A
    Egashira, K
    [J]. CIRCULATION, 2004, 109 (20) : 2454 - 2461
  • [5] Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration
    Iwaguro, H
    Yamaguchi, J
    Kalka, C
    Murasawa, S
    Masuda, H
    Hayashi, S
    Silver, M
    Li, T
    Isner, JM
    Asahara, T
    [J]. CIRCULATION, 2002, 105 (06) : 732 - 738
  • [6] Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes
    Jin, David K.
    Shido, Koji
    Kopp, Hans-Georg
    Petit, Isabelle
    Shmelkov, Sergey V.
    Young, Lauren M.
    Hooper, Andrea T.
    Amano, Hideki
    Avecilla, Scott T.
    Heissig, Beate
    Hattori, Koichi
    Zhang, Fan
    Hicklin, Daniel J.
    Wu, Yan
    Zhu, Zhenping
    Dunn, Ashley
    Salari, Hassan
    Werb, Zena
    Hackett, Neil R.
    Crystal, Ronald G.
    Lyden, David
    Rafii, Shahin
    [J]. NATURE MEDICINE, 2006, 12 (05) : 557 - 567
  • [7] Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
    Kalka, C
    Masuda, H
    Takahashi, T
    Kalka-Moll, WM
    Silver, M
    Kearney, M
    Li, T
    Isner, JM
    Asahara, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3422 - 3427
  • [8] Kawamoto A, 2001, CIRCULATION, V103, P634
  • [9] Kryczek I, 2005, CANCER RES, V65, P465
  • [10] Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: A double-blind randomized trial
    Kusumanto, Y. H.
    Van Weel, V.
    Mulder, N. H.
    Smit, A. J.
    Van den Dungen, J. J. A. M.
    Hooymans, J. M. M.
    Sluiter, W. J.
    Tio, R. A.
    Quax, P. H. A.
    Gans, R. O. B.
    Dullaart, R. P. F.
    Hospers, G. A. P.
    [J]. HUMAN GENE THERAPY, 2006, 17 (06) : 683 - 691